Background: MicroRNAs play a crucial role in the regulation of pathological cardiac remodeling and heart failure. Previously, we found that overexpression of miR-221 induces heart failure in mice. The miR-222 and miR-221 share the same gene cluster, however, the role of miR-222 in the regulation of cardiac function remained ill-defined. Methods and Results: Transgenic mice with cardiac-specific expression of miR-222 (Tg-miR-222) mice were generated. The Tg-miR-222 mice developed significantly enlarged hearts at 4 weeks of age. Transthoracic echocardiograph data indicated that the hearts of Tg-miR-222 mice exhibited an increased left ventricular end-diastolic internal diameter and decreased fractional shortening. We observed that the LC3-II in Tg-miR-222 mice was decreased accompanied with the upregulation of p62, indicating the autophagy inhibition in the hearts of Tg-miR-222 mice. The mTOR pathway, a negative regulator of autophagy, was activated in the hearts of Tg-miR-222 mice. The expression of p27 was downregulated by miR-222 overexpression. Conclusion: Our data indicate that miR-222 overexpression induces heart failure in mice. The downregulation of p27 and the activation of mTOR pathway may be involved in miR-222-induced heart failure and autophagy inhibition. Thus, targeting miR-222 expression may be a therapeutic strategy against pathological cardiac remodeling.
Cardiac-Specific Overexpression of miR-222 Induces Heart Failure and Inhibits Autophagy in Mice
regulatory molecules that can play a critical role in heart failure [1] . Previously, we found that miR-221 is a pro-hypertrophic miRNA, both in vitro and in vivo [2, 3] . The hearts of miR-221 cardiac-specific transgenic mice showed pathological cardiac hypertrophy and severe heart failure [3] . Further investigation indicated that miR-221-induced cardiac remodeling is associated with the downregulation of p27, activation of the mTOR pathway, and the subsequent inhibition of autophagy in cardiomyocytes [3] . The p27 gene is robustly expressed in adult cardiomyocytes, and it plays an anti-hypertrophic role in response to adverse stimulations [4] [5] [6] . Furthermore, p27 was also found to protect cardiomyocytes from apoptosis by inducing autophagy during metabolic stress [7] . These data highlight that p27 is a key negative regulator of pathological cardiac remodeling.
Human miR-222 and miR-221 encoding genes are located on the X chromosome and share the same gene cluster. Additionally, the sequences of these two mature miRNAs are similar, and their binding sites are identically conserved. Therefore, the target genes of these two miRNAs closely coincide. The p27 gene is a bona fide target of the miR-221/ miR-222 cluster [8] [9] [10] [11] [12] [13] . In exercise-induced cardiac growth and acute heart injury models, the expression of miR-222 is upregulated and promotes cardiomyocyte proliferation [14] . Therefore, we hypothesize that cardiac-specific overexpression of miR-222 might impair normal cardiac function by targeting p27. In the present study, we investigated whether miR-222 showed similar effects as miR-221 in the heart. By constructing transgenic mice with cardiac-specific expression of miR-222 (Tg-miR-222), we found that Tg-miR-222 mice experience severe heart failure.
Materials and Methods

Animal studies
All of the animal studies were approved by the Ethics Committee for Animal Study of Fuwai Hospital (Beijing, China). The protocol for the construction of Tg-miR-222 mice was followed as previously described [3] . Briefly, the encoding gene of the miR-222 precursor was amplified by using the following primers: forward, 5'-GCG AGC TCG GCG GGG AGA GGG T-3'; reverse, 5'-CGC CGA AGC TTA GAT GAT ACA TAG ACA GCT GGA TAG-3'. The PCR product was digested with SacI and HindIII (TaKaRa, Dalian, China), and cloned into a pBSII-α-MHC-hGH vector driven by the murine α-MHC promoter. The constructs were then digested with NotI to linearize the plasmid. The products were injected into the pronucleus of fertilized zygotes from C57BL/6J mice, and then transferred to the oviducts of pseudopregnant ICR recipients. The genotypes of all the transgenic mice were verified by PCR analysis using tail genomic DNA and the following primers: 5′-GAC AGC AGA TCA CGA TTC TCC CG-3′ and 5′-CTG AGG GCA CCC TAA TCC TTC TGA GAG TTA GAC A-3′. The Fabpi gene was amplified as a control, using the following primers: forward, 5′-TGG ACA GGA CTG GAC CTC TGC TTT CCT AG A-3′; reverse, 5′-TAG AGC TTT GCC ACA TCA CAG GTC ATT CAG-3′. At 4 weeks of age, male transgenic mice were used for further analysis.
Transthoracic echocardiography
Transthoracic echocardiography analysis was performed as previously described [15] . In brief, the mice at both 4 and 16 weeks of age were weighed and anesthetized using 2.5% Avertin (0.018 ml/g). The two-dimensional short and long axes of the left ventricular (LV) were detected using a 30-MHz probe interfaced with a Vevo-770 high-frequency ultrasound system (VisualSonics, Toronto, ON, Canada). The LV end-diastolic internal diameter (LVIDd), LV end-systolic internal diameter (LVIDs), LV posterior wall thickness at the end of diastole (LVPWd) and LV anterior wall thickness at the end of diastole (LVAWd) were detected by using M-mode recordings. The fractional shortening (FS) measurements were calculated with the following formula: FS% = (LVIDd −LVIDs)/LVIDd × 100%.
Morphological analysis
The hearts were fixed with 4% paraformaldehyde, dehydrated, and embedded in paraffin. The paraffin sections were stained with Masson's trichrome reagents for histological analysis. The collagen deposition The collagen deposition (%) was calculated with fibrotic area/total area ×100% in each field, and at least 5 random fields were observed for each mouse.
Terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling staining
The terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) assay was performed using the in situ cell death detection kit, POD (Roche Diagnostics GmbH, Germany), according to the manufacturer's protocol. Briefly, tissue sections were de-paraffinized and rehydrated. The endogenous peroxidase was blocked with 3% H 2 O 2 for 30 min. Next, the sections were digested with Proteinase K for 30 min at room temperature, and then incubated with TdT enzyme containing digoxigenin-dUTP working solution. The reaction was stopped, washed, and subsequently incubated with a POD working solution. The peroxidase activity was detected by adding diaminobenzidine. The sections were then stained with hematoxylin. The images in each section were obtained with an Olympus IX71 microscope (Tokyo, Japan). The TUNEL + and total nuclei were counted blind to mouse genotype. The apoptosis was calculated as TUNEL + nuclei/total nuclei ×100%, and at least 5 random fields were measured for each mouse.
Cell culture and transfection
Primary neonatal rat cardiomyocytes (NRCM) were isolated and cultured as previously described [2] . In brief, hearts from neonatal Wistar rats were isolated and minced. The heart tissues were digested with 0.06% collagenase (Worthington Biochemical Corporation, Lakewood, NJ, USA) at 37°C. The cells were subjected to differential adhesion and plated in DMEM medium supplemented with 10% FBS and 0.1 mM bromodeoxyuridine. The cells were then plated and acclimated for 24 before treatment.
The cells were transfected with the miRNA mimic using Lipofectamine 2000 transfection reagent (Life Technologies), according to manufacturer's protocol. The final concentration of the miRNA mimic was 100 nM.
RNA analysis
Total RNA was extracted and isolated by using a miRNeasy Mini Kit (Qiagen, Hilden, Germany). The expression of miR-222 and miR-221 in the hearts of NTG and Tg-miR-222 mice was detected by quantitative RT-PCR. U6 was employed as the loading control. The relative expression was expressed as the ΔCt (compressive tracking) value. For the quantitative RT-PCR assay, complementary DNAs (cDNAs) were synthesized using a cDNA synthesis kit (TaKaRa, Dalian, China). The following specific primers were used: mouse atrial natriuretic peptide (ANP), 5′-AGT GCG GTG TCC AAC ACA G-3′ and 5′-TGC TTC CTC AGT CTG CTC ACT C-3′; mouse brain natriuretic peptide (BNP), 5′-CTT TAT CTG TCA CCG CTG GGA G-3′ and 5′-TTT GGG TGT TCT TTT GTG AGG C-3′; mouse GAPDH, 5′-GGC ATT GTG GAA GGG CTC-3′ and 5′-GGG GGT AGG AAC ACG GAA G-3′.
Protein analysis
Proteins were extracted and quantified. A total of 20-50 μg of protein was loaded onto SDS polyacrylamide gels for electrophoretic separation. Then, the proteins were transferred onto a nitrocellulose membrane and blocked with 5% non-fat dry milk at room temperature for 1 h. The following primary antibodies were used and diluted to 1:1000 in TBST buffer for incubation: p27, p62, and GAPDH (Cell Signaling Technology, Beverly, MA, USA); the rabbit anti-LC3B antibody was purchased from Sigma-Aldrich (St. Louis., MO, USA). The membrane was then washed and incubated with HRP-conjugated secondary antibody for 1 h at room temperature. The bands were detected with SuperSignal West Femto Maximum Sensitivity Substrate (Pierce, Rockford, IL, USA). The intensity of each band was quantified by using Quantity One software, V4.6.2 (Bio-Rad, Hercules, CA, USA).
Statistical analysis
Statistical analysis was performed with SPSS 19.0 software (SPSS Inc., Chicago, IL, USA). A twotailed Student's t-test was used to determine the statistical significance between two groups. P<0.05 was considered statistically significant. The data are presented as the mean ± S.D.
Results
Cardiac-specific overexpression of miR-222 induces heart failure in transgenic mice
To investigate the effect of miR-222 on the heart in vivo, we constructed transgenic mice with cardiac-specific expression of miR-222. The expression of miR-222 in the hearts of Tg-miR-222 mice was significantly higher than in their non-transgenic (NTG) littermates. The expression of miR-221, however, showed no difference between the two groups (Fig.  1A) . The hearts of the Tg-miR-222 mice were significantly enlarged compared with the NTG mice (Fig. 1B) . A histological analysis indicated that the ventricle chamber was significantly enlarged (Fig. 1C) . The heart-to-body and lung-to-body ratios were both increased in TgmiR-222 mice ( Fig. 1D and E) , indicating that overexpression of miR-222 could result in heart failure. Accordingly, the expression of ANP and BNP in Tg-miR-222 mice was 18.6-and 5.8-fold higher than that of NTG mice, respectively (Fig. 1F) .
We then detected the cardiac function in mice at both 4 and 16 weeks of age using high-resolution echocardiography ( Fig. 2A) . We found that the LVIDd was increased in TgmiR-222 mice; however, the LVAWd and LVPWd showed no differences between NTG and Tg-miR-222 mice at 4 and 16 weeks of age ( Fig. 2B-I ). The FS%, a parameter that reflects cardiac function, was significantly decreased in Tg-miR-222 mice compared with their NTG littermates (Fig. 2E ). These data indicated that overexpression of miR-222 led to pathological cardiac remodeling and impaired the cardiac function in vivo. 
miR-222 induces cardiac fibrosis and apoptosis in vivo
Cardiac fibrosis and apoptosis are important pathological changes in cardiac remodeling. Using Masson's trichrome staining, we observed an excessive deposition of collagen in the myocardia of Tg-miR-222 mice (Fig. 3A and B) . Moreover, the number of TUNEL-positive cells was increased in the myocardial tissues of Tg-miR-222 mice, which indicated that constitutive overexpression of miR-222 in cardiomyocytes could induce apoptosis in vivo (Fig. 3C and D) . These results indicated that overexpression of miR-222 resulted in a severe cardiac fibrosis and a diminished number of cardiomyocytes, which may be directly associated with the impairment of cardiac function in Tg-miR-222 mice.
miR-222 downregulates p27 in cardiomyocytes
Previously, our results indicated that miR-221 could induce cardiac remodeling through targeting p27 expression. Because p27 was also predicted as a target of miR-222, we therefore detected the expression of p27 in NRCM transfected with the miR-222 mimic. We observed that the expression of p27 was dramatically downregulated in miR-222-transfected NRCM (Fig. 4A and B) . Accordingly, the expression of p27 was downregulated in the hearts of TgmiR-222 mice (Fig. 4C and D) , indicating that p27 could be downregulated by miR-222, both in vitro and in vivo. tissues of Tg-miR-222 mice, as shown by the increased phosphorylation of mTOR and S6 (Fig. 5D-F) . Taken together, our data demonstrated that miR-222 inhibited autophagy in cardiomyocytes and may be associated with the downregulation of p27 and the activation of mTOR pathway.
Discussion
The present study uncovered the role of miR-222 in the regulation of pathological cardiac remodeling. We found that cardiac-specific overexpression of miR-222 resulted in significant heart failure. Moreover, miR-222 downregulated the expression of p27 and mediated the regulation of autophagy in the heart. Our results indicated that miR-222 participated in the regulation of pathological cardiac remodeling and heart failure.
Pathological cardiac remodeling is a chronic process that is orchestrated by a group of cardiac-associated miRNAs. The roles of these miRNAs may vary according to the context or phase of cardiac remodeling. In exercise-induced cardiac growth, the upregulation of miR-222 promoted cell proliferation [14] . These effects were mediated by targeting HIPK1 and HMBOX1 [14] . In contrast, we observed that cardiac-specific overexpression of miR-222 in vivo induced a severe impairment in cardiac function, as indicated by increased ANP and BNP expression, cardiac fibrosis, and apoptosis in the heart tissues; all of which, suggest cardiac remodeling.
In miR-221 transgenic mice, the downregulation of p27 contributed to the inhibition of pathological cardiac remodeling and heart failure [3] . In angiotensin II-induced cardiac remodeling models, an increase of p27 protects against cardiac hypertrophy [5, 6] . Previous reports suggest that p27 is a bona fide target gene of miR-222 in various cell lines [8] [9] [10] [11] [12] . Our data revealed that p27 was downregulated by miR-222 overexpression in cardiomyocytes, both in vitro and in vivo, which indicated that downregulation of p27 may be involved in miR-222-induced cardiac remodeling and heart failure. Autophagy is an important process that maintains normal cardiomyocyte function, whereas uncontrolled autophagy leads to cardiac remodeling [16] [17] [18] [19] [20] [21] [22] . Autophagy inhibition impairs the cardiac function, which is associated with decreased clearance of protein aggregates, deteriorating injured organelles [23] . Blunting of autophagy by inhibit Atg5 expression induced an impairment of cardiac function [16] . In Tg-miR-222 mice, we also observed a significant inhibition of autophagy, as evidenced by the decrease of LC3-II and increase of p62. These changes of autophagy induced by miR-222 may result in an accumulation of protein aggregates and injured organelles, which may be associated with the impairment of cardiac function.
The activation of autophagy is precisely regulated by various signaling pathways. The p27 and mTOR signaling pathway play pivotal roles in regulating the level of autophagy. In our previous study, we found that miR-221 suppresses autophagy by directly targeting p27, and the autophagy impairment is indispensable to miR-221-induced heart failure [3] . It has been well known that the miR-222 and miR-221 locate in the same gene cluster, and their seed sequences are identical. These two miRNAs share many target genes. By targeting p27, miR-221 inhibited cardiac autophagy by modulating the mTOR axis [3] . In the present study, we found that miR-222 inhibited p27 and resulted in cardiac dysfunction and autophagy impairment, same as what miR-221 did. miR-222 overexpression induced the activation of the mTOR pathway. The role of miR-222 in the regulation of mTOR activation is not understood, however, the downregulation of p27 may be involved. The robust expression of p27 can protect stressed adult hearts by activating autophagy to avoid apoptosis [7] . Consistently, our data showed that apoptosis in the hearts of Tg-miR-222 mice was increased, supporting that the downregulation of p27 and autophagy inhibition may be associated with the pathological cardiac remodeling and heart failure induced by miR-222 overexpression.
Our study revealed that cardiac-specific overexpression of miR-222 could induce pathological cardiac remodeling and heart failure, which may be associated with the p27/ mTOR/autophagy axis. Our results suggest that miR-222 may be a potential therapeutic target for cardiac remodeling and heart failure.
